Promising new drugs for gynecological cancer

Japanese Journal of Cancer and Chemotherapy

Volumn 24, Issue 13, 1997, Pages 1932-1937

  Yakushiji, M ^a   Sugiyama, T ^a   Ushijima, K ^a  

^a KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Cervical cancer; Docetaxel; Irinotecan hydrochloride; Nedaplatin; Ovarian cancer; Paclitaxel; Topotecan

Indexed keywords

CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; DEXAMETHASONE; DIPHENHYDRAMINE; DOCETAXEL; DOXORUBICIN; GRANULOCYTE COLONY STIMULATING FACTOR; IRINOTECAN; MITOMYCIN C; NEDAPLATIN; NEW DRUG; PACLITAXEL; RANITIDINE; TOPOTECAN;

CLINICAL TRIAL; DIARRHEA; DRUG HYPERSENSITIVITY; GYNECOLOGIC CANCER; HUMAN; INTRAPERITONEAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; NEPHROTOXICITY; NEUTROPENIA; ORAL DRUG ADMINISTRATION; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; REVIEW;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CAMPTOTHECIN; CISPLATIN; CLINICAL TRIALS, PHASE I; CYCLOPHOSPHAMIDE; DRUG ADMINISTRATION SCHEDULE; FEMALE; GENITAL NEOPLASMS, FEMALE; HUMANS; ORGANOPLATINUM COMPOUNDS; PACLITAXEL; TAXOIDS; TOPOTECAN;

EID: 0030827420     PISSN: 03850684     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (24)